# US 2023/0406823 A1 · 4-pivaloyloxy-n-methyltryptammonium chloride

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0406823 A1
- Document ID: US20230406823A1
- Status: Published application
- Kind: A1
- Application number: 18/051,228
- Filed: 2022-10-31
- Published: 2023-12-21
- Earliest claimed: 2022-06-09
- Assignees: Caamtech, Inc.
- Applicants: Caamtech, Inc.
- Inventors: Andrew R. CHADEAYNE
- Web page: https://patentgrep.com/patent/US20230406823A1

## CPC

- C07D 209/16: Tryptamines
- A61K 31/4045: Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 23/00: Anaesthetics
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 25/24: Antidepressants
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The disclosure relates to (2-{4-[(2,2-dimethylpropanoyl)oxy]-1H-indol-3-yl}ethyl)(methyl)azanium chloride (4-pivaloyloxy-N-methyltryptammonium chloride), crystalline 4-pivaloyloxy-N-methyltryptammonium chloride, and specific crystalline forms thereof, including crystalline form 1 of 4-pivaloyloxy-N-methyltryptammonium chloride, to compositions containing the same, and to methods of treatment using them.

## Claims

### Claim 1

(2-{4-[(2,2-dimethylpropanoyl)oxy]-1H-indol-3-yl}ethyl)(methyl)azanium chloride (4-pivaloyloxy-N-methyltryptammonium chloride).

### Claim 2

(canceled)

### Claim 3

(canceled)

### Claim 4

A crystalline form 1 of (2-{4-[(2,2-dimethylpropanoyl)oxy]-1H-indol-3-yl}ethyl)(methyl)azanium chloride (4-pivaloyloxy-N-methyltryptammonium chloride), characterized by at least one of:
an orthorhombic crystal system at a temperature of about 297 K;
a Pbca space group at a temperature of about 297 K;
unit cell dimensions a=17.6586(11) Å, b=9.3207(7) Å, c=20.3054(15) Å, α=900, β=90°, and γ=90°;
an X-ray powder diffraction pattern substantially similar to FIG. 3; or
an X-ray powder diffraction pattern characterized by at least two peaks selected from 8.7, 11.6, and 13.8° 2θ±0.2° 2θ.

### Claim 5 (depends on 1)

A composition comprising 4-pivaloyloxy-N-methyltryptammonium chloride according to claim 1 and an excipient.

### Claim 6 (depends on 4)

A composition comprising crystalline 4-pivaloyloxy-N-methyltryptammonium chloride according to claim 4 and an excipient.

### Claim 7 (depends on 1)

A composition comprising 4-pivaloyloxy-N-methyltryptammonium chloride according to claim 1 as a first component and a second component selected from at least one of (a) a serotonergic drug, (b) a purified psilocybin derivative, (c) a purified cannabinoid, (d) a purified terpene, (e) an adrenergic drug, (f) a dopaminergic drug, (g) a monoamine oxidase inhibitor, (h) a purified erinacine, and (i) a purified hericenone.

### Claim 8 (depends on 4)

A composition comprising crystalline 4-pivaloyloxy-N-methyltryptammonium chloride according to claim 4 as a first component and a second component selected from at least one of (a) a serotonergic drug, (b) a purified psilocybin derivative, (c) a purified cannabinoid, (d) a purified terpene, (e) an adrenergic drug, (f) a dopaminergic drug, (g) a monoamine oxidase inhibitor, (h) a purified erinacine, and (i) a purified hericenone.

### Claim 9 (depends on 1)

A method of preventing or treating a psychological disorder comprising the step of:
administering to a subject in need thereof a therapeutically effective amount of 4-pivaloyloxy-N-methyltryptammonium chloride according to claim 1.

### Claim 10 (depends on 4)

A method of preventing or treating a psychological disorder comprising the step of:
administering to a subject in need thereof a therapeutically effective amount of crystalline 4-pivaloyloxy-N-methyltryptammonium chloride according to claim 4.

### Claim 11 (depends on 5)

A method of preventing or treating a psychological disorder comprising the step of:
administering to a subject in need thereof a composition according to claim 5.

### Claim 12 (depends on 6)

A method of preventing or treating a psychological disorder comprising the step of:
administering to a subject in need thereof a composition according to claim 6.

### Claim 13 (depends on 1)

A method of preventing or treating inflammation and/or pain comprising the step of:
administering to a subject in need thereof a therapeutically effective amount of 4-pivaloyloxy-N-methyltryptammonium chloride according to claim 1.

### Claim 14 (depends on 4)

A method of preventing or treating inflammation and/or pain comprising the step of:
administering to a subject in need thereof a therapeutically effective amount of crystalline 4-pivaloyloxy-N-methyltryptammonium chloride according to claim 4.

### Claim 15 (depends on 5)

A method of preventing or treating inflammation and/or pain comprising the step of:
administering to a subject in need thereof a composition according to claim 5.

### Claim 16 (depends on 6)

A method of preventing or treating inflammation and/or pain comprising the step of:
administering to a subject in need thereof a composition according to claim 6.

### Claim 17 (depends on 7)

A method of preventing or treating a psychological disorder comprising the step of:
administering to a subject in need thereof a composition according to claim 7.

### Claim 18 (depends on 8)

A method of preventing or treating a psychological disorder comprising the step of:
administering to a subject in need thereof a composition according to claim 8.

### Claim 19 (depends on 7)

A method of preventing or treating inflammation and/or pain comprising the step of:
administering to a subject in need thereof a composition according to claim 7.

### Claim 20 (depends on 8)

A method of preventing or treating inflammation and/or pain comprising the step of:
administering to a subject in need thereof a composition according to claim 8.
